SAN DIEGO — Livdelzi appeared safe and well-tolerated and reduced markers of cholestasis and liver injury in patients with primary biliary cholangitis, including those with compensated cirrhosis, according to a presenter. Previous data from the phase 3, placebo-controlled RESPONSE trial have shown that Livdelzi (seladelpar, Gilead) significantly improved biomarkers of cholestasis over 12
A podcast hosted by Shikha Jain, MD, FACP, covering modern day health care in an ever-evolving world. Watch 2024 episodes on Healio today.
The FDA has cleared an investigational new drug application for the RespiRx Nicotine Inhaler (QN-01), an inhaled nicotine replacement therapy, according to a press release.With…
PHILADELPHIA — Despite the growing prevalence of wearable devices, more research is needed before they can be used to predict and monitor COPD exacerbations, according…
Gastrointestinal Endoscopy is pleased to present the GIE Audio and Podcasts program. Users can listen to podcasts on their computer or mp3 player by clicking…
WASHINGTON — The correlation between autoantibodies and new-onset autoimmune disease in individuals with long COVID symptoms remains “controversial,” according to a speaker at ACR Convergence…
Post written by Celine Busch, MD, and Annieke van Baar, MD, PhD, from Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. The duodenum has proven…
People with type 2 diabetes had twice the number of CVD events vs. matched counterparts, with events starting 3 decades before diagnosis, suggesting their elevated…
Objective Extracellular matrix protein 1 (ECM1) serves as a gatekeeper of hepatic fibrosis by maintaining transforming growth factor-β1 (TGF-β1) in its latent form. ECM1 knockout…
Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a diagnosis of IBS cannot be made, the prevalence…
Background There is no clinically relevant serological marker for the early detection of oesophageal adenocarcinoma (EAC) and its precursor lesion, Barrett’s oesophagus (BE). Objective To…
